Donate

Donate

February 17, 2005 | Part Of Safety of Arthritis Drugs, Day 2,

Safety of Arthritis Drugs, Day 2, Part 4

The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint me… read more

The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhibitors such as Bextra, Celebrex, and Vioxx. Participants suggested other studies that are needed to insure long-term drug safety.

The function of the advisory committees is to provide advice and recommendations to the FDA on regulatory issues. close

Report Video Issue

People in this video

Steven Abramson Chair New York University Medical School->Rheumatology
Joan Bathon Professor Johns Hopkins University School of Medicine

Stephanie Crawford Professor University of Illinois at Chicago->Pharmacy
Byron Cryer M.D. Professor University of Texas at Dallas->Southwestern Medical School
Sean Curtis Senior Director Merck Research Laboratories->Clinical Research
Ralph D'Agostino Professor Boston University->Public Health and Statistics
Michael Domanski Head National Heart, Lung, and Blood Institute->Clinical Trial Group
Robert Dworkin Director University of Rochester->Anesthesiology Research
Janet Elashoff Director Cedars-Sinai Medical->Biostatistics
John Farrar Director University of Pennsylvania->Clinical Epidemiology and Biostatistics
Garret Fitzgerald M.D. Professor University of Pennsylvania School of Medicine
Thomas Fleming Chairman University of Washington->Biostatistics
Lawrence Friedman Official National Institutes of Health
Curt Furberg Director Wake Forest University->Department of Public Health Services
Allan Gibofsky Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
Peter Gross M.D. Chairman Hackensack University Medical Center->Internal Medicine
Charles Hennekens Professor University of Miami->School of Medicine
Gary Hoffman Research Director Cleveland Clinic Foundation->Vasculitis Center
Eric Holmboe Vice President American Board of Internal Medicine->Evaluation Research
Norman Ilowite Chief Schneider Children's Hospital
Peter Kim President Merck Research Laboratories
Arthur Levin Director Center for Medical Consumers
Leona Malone
Susan Manzi Professor University of Pittsburgh->School of Medicine
Patrice Matchaba Medical Director Novartis Pharmaceuticals Corporation->Global
Louis Morris President Louis A. Morris and Associates
Steven E. Nissen M.D. Medical Director Cleveland Clinic Foundation->Cardiovascular Coord. Ctr.
Robert O'Neil Director U.S. Food and Drug Administration->Biostatistics
Emil Paganini Head Cleveland Clinic Foundation->Dialysis Section
Richard Platt Director Harvard Medical School->Ambulatory Care and Prevention
Joel Schiffenbauer Medical Officer U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Steven Shafer M.D. Professor Stanford University->Medical School
Robyn Shapiro Professor Medical College of Wisconsin->Bioethics
Gurkipal Singh M.D. Professor Stanford University->School of Medicine
Annette Stemhagen Official Covance Periapproval Services
Robert Temple Director U.S. Food and Drug Administration->Office of Drug Evaluation
Lourdes Villalba M.D. Research Analyst U.S. Food and Drug Administration
Alastair J. J. Wood M.D. Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.

More People

Hosting Organization

U.S. Food and Drug AdministrationU.S. Food and Drug Administration

More Videos From

Safety of Arthritis Drugs, Day 2,

499 Views

Program ID:: 185588-4
Category:: Public Affairs Event
Format:: Forum
Location:: Gaithersburg, Maryland, United States
First Aired:: Feb 24, 2005 | 3:36pm EST | C-SPAN 2

Airing Details

Feb 24, 2005 | 3:36pm EST | C-SPAN 2

MP3 audio - Standard

Price:

$0.99

Request Download
Alert me when the download is available.
- Name
- Email
Error requesting format availability.

Your request has been submitted.
There was an error processing your purchase.

Related Video

See all on Research Drugs (Pharmaceuticals) Research Safety

May 6, 2006
Presidential Radio Address

In his weekly radio address President Bush talked about the May 15 deadline for signing up for the new Medicare prescrip…
April 30, 2007
Prescription Drug Safety

Food and Drug Administration Commissioner Andrew C. von Eschenbach talked about efforts to balance drug safety, risk, be…
January 7, 2008
The Vioxx Settlement

A panel discussion was held about the settlement Merck made with users of its pain reliever Vioxx, which it withdrew fro…
February 19, 2008
FDA Oversight

Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional ove…